Metabolic adaptability in metastatic breast cancer by AKR1B10-dependent balancing of glycolysis and fatty acid oxidation
Cancer cells must develop distinct metabolic adaptations to survive in challenging metastatic environments. Here, the authors find, via an in vivo RNAi screen, that the aldo-keto reductase AKR1B10 limits the toxic side effects of oxidative stress to sustain fatty acid oxidation and promote metastati...
Main Authors: | Antoinette van Weverwijk, Nikolaos Koundouros, Marjan Iravani, Matthew Ashenden, Qiong Gao, George Poulogiannis, Ute Jungwirth, Clare M. Isacke |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-06-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-10592-4 |
Similar Items
-
Impairment of a distinct cancer-associated fibroblast population limits tumour growth and metastasis
by: Ute Jungwirth, et al.
Published: (2021-06-01) -
Generation and characterisation of two D2A1 mammary cancer sublines to model spontaneous and experimental metastasis in a syngeneic BALB/c host
by: Ute Jungwirth, et al.
Published: (2018-01-01) -
Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer
by: Nikos Koundouros, et al.
Published: (2018-05-01) -
Using an in-vivo syngeneic spontaneous metastasis model identifies ID2 as a promoter of breast cancer colonisation in the brain
by: Magdalena Kijewska, et al.
Published: (2019-01-01) -
AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas
by: Marko Hojnik, et al.
Published: (2021-07-01)